Kabra Drugs informs about standalone financial results

15 Nov 2016

Kabra Drugs has informed about Standalone Financial Results for the period ended September 30, 2016 and Standalone Limited Review for the period ended September 30, 2016.

The above information is a part of company’s filings submitted to BSE.

Related Kabra Drugs Ltd. Links:

Kabra Drugs Share Price

1.94 0.03 (1.57%) Feb 18, 18:01
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 408.70
Lupin 705.80
Dr. Reddys Lab 3250.20
Piramal Enterprises 1522.30
Cadila Healthcare 268.00
View more..
Sensex vs Kabra Drugs
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback

8055769463

8055769463